Skip to content

Multidimensional Advantages of Integrated Traditional Chinese and Western Medicine in the Treatment of Hyperuricemia: A Prospective Cohort Study

Multidimensional Advantages of Integrated Traditional Chinese and Western Medicine in the Treatment of Hyperuricemia: A Prospective Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126487
Enrollment
Unknown
Registered
2026-06-09
Start date
2026-06-09
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperuricemia

Interventions

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Meets the diagnostic criteria for hyperuricemia; 2. Age between 18 and 70 years old (inclusive), gender not restricted; 3. Understands and agrees to participate in this study and signs the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients who have used any uric acid-lowering drugs regularly or intermittently within the past two weeks; 2. Patients diagnosed with secondary hyperuricemia; 3. Patients with severe primary diseases such as cardiovascular, cerebrovascular, liver, kidney and hematological disorders; 4. Pregnant or lactating women; 5. Patients with a history of malignant tumors.

Design outcomes

Primary

MeasureTime frame
Serum Uric Acid Target Achievement Rate;

Secondary

MeasureTime frame
Sustained sUA Goal Attainment Rate;Annual Frequency of Gout Flares;Frequency of Kidney Stone Colic Attacks;Rate of eGFR Change;Changes in Metabolic Syndrome Components;Overall Effective Rate of TCM Syndrome;Incidence Rate of Cardiovascular Events;

Countries

China

Contacts

Public ContactYi Li; Luan Xue

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine

xelco@163.com+86 189 3056 8151

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 21, 2026